CytoSure™ Medical Research Exome Array
Comprehensive coverage of over 4600 hand-curated, research-validated genes at exon-level resolution.
The CytoSure Medical Research Exome Array is a highly targeted exon-focused array capable of detecting relevant microdeletions and microduplications. This array has been developed in collaboration with leading molecular genetics experts at Emory University in a research setting and makes an ideal complement to an exome sequencing approach to provide a comprehensive mutation spectrum analysis in rare disease.
The CytoSure Medical Research Exome Array delivers:
- Highly targeted optimised probes — detect single or multiple exonic CNVs
- Medical research relevant content — over 4600 hand-curated, research-validated genes
- Bespoke custom array design service — select from our proprietary Medical Research Exome database
- Optimised labelling kits and integrated sample tracking probes — for confident analysis and reporting
NGS is currently limited in its detection of CNVs, and we employ the CytoSure Medical Research Exome Array (MREA) alongside both genome and exome sequencing for detecting additional variants, strengthening the evidence towards the detection of a particular disorder. The MREA has been used in our research looking at families where NGS has identified one compelling variant, and we are looking for that second disease-linked variant. We see great benefits for this approach in instances where there is no clear phenotype associated with a particular disorder. The OGT MREA provides us with the exon-level resolution needed to detect CNVs over the medical exome that are missed by NGS and traditional microarray designs, providing additional insights into the mutation spectrum of the sample. Even as NGS continues to develop, microarrays remain critical to detecting CNVs. Dr Emily Farrow, Director of Laboratory Operations and member of the analysis team at the Center for Pediatric Genomic Medicine, Children's Mercy Hospital in Kansas City
Highly targeted optimised probes
Using a proprietary probe design algorithm, we are able to design highly targeted, optimised probes throughout the majority of the genome. A range of probe performance metrics are evaluated to ensure optimal array performance. A poorly performing probe can result in inaccurate data and even false calls. All of our probes are first tested in silico and scored on quality. Probes with the highest score are printed on an array and tested in the laboratory. These probes are ranked on performance, and only the most accurate, best performing probes are used in the final design. Probes have been selected to target the exonic regions of 4,645 genes. For the majority of genes there are a minimum of 4 probes per exon. For very large exons, probes are distributed evenly along the exon with 1 probe every 125bp. For any array design, it is also important to provide good backbone coverage to ensure accurate normalisation. In the untargeted backbone, the CytoSure Medical Research Exome array has one probe every 42kb. Using optimised probes enables the detection of small amplifications and deletions (Figure 1). To view a complete list of genes covered by this array contact us.
Figure 1: CytoSure Interpret Software clearly displays small aberrations and enables easy identification of genes and exons. Duchenne muscular dystrophy (DMD) is caused by a mutation in the DMD gene, which is one of the largest genes in the genome with over 79 exons. Shown here in the top panel is the complete view of the whole gene. The bottom panel is a close-up view showing a small duplication of 1.4kb in the DMD gene which spans a single exon. Mutations in TRPM1 are often associated with congenital stationary night blindness. Shown here in the top panel is an overview of the whole gene. In the bottom panel, the close-up view shows a very small 684bp deletion which contains 10 probes, and also spans a single exon. Data kindly provided by Madhuri Hegde, Ph.D., FACMG, Emory University.
Medical research relevant content
Working with the leading clinical research experts at Emory University has enabled us to design an array covering the most relevant regions of the genome gathered from their research into molecular disorders. It has been hand-curated and grouped into disease- and syndrome specific research panels. The content of the CytoSure Medical Research Exome Array is grouped into over sixty different panels. Each panel contains genes relevant to a specific syndrome or genetically linked disease. Working with these panels has enabled Emory Genetics to create a set of ten 4x180k custom arrays containing probes validated on the CytoSure Medical Research Exome Array. These custom arrays provide a more cost-effective, routine option for detailed research into small, exon-specific aberrations.
Bespoke custom array design service
Genetic research into molecular disorder samples is typically done in batches to ensure cost-effective processing. However, collecting sufficient samples, especially for rare disorders can significantly delay analysis. Combining content for rare disorders with more commonly occurring conditions on to a single array allows immediate processing of a diverse range of samples, thereby reducing both time to analysis and cost. Select from our proprietary database of over 26 million in silico validated probes and build a bespoke custom array based on your laboratory's requirements. Four array formats are available, 8x60k, 4x180k, 2x400k and 1x1M, allowing you to choose the one most suited to your content and throughput needs. Like all of our arrays, custom arrays are optimised to work with our range of high-quality labelling kits and are supplied with CytoSure Interpret Software, our class-leading data analysis package. It is easy to get started as full on-site wet lab and data analysis training is provided as standard. OGT validation data and customer feedback confirms that using CytoSure Genomic DNA Labelling Kits improves DLRS values and signal-to-noise ratios, ensuring accurate detection of even the smallest aberration. Poor quality metrics from using non-optimised kits can indicate an increased level of technical noise on the array which may have an impact on the ability to detect small aberrations.
Easy data interpretation
CytoSure Interpret Software is a powerful, easy-to-use package for the analysis of aCGH data. Innovative features such as the Accelerate Workflow enable standardised and automated data analysis, including automatic aberration detection and classification. It includes extensive annotation tracks covering syndromes, genes, exons, CNVs and recombination hotspots — each of which link to publicly available databases such as ISCA, Decipher and the Database of Genomic Variants and the Cancer Gene Consensus Genes (Figure 2) providing results in context. It is possible to select which tracks are displayed allowing only tracks of specific interest to be viewed (e.g. syndrome-specific tracks) ensuring easy data interpretation. Each track can reference hg18, hg19 or GRCh38 (hg20) information. Annotations within a track can be coloured allowing easy visualisation. It is also possible to customise what information from the tracks is saved in the report (e.g. how many common variants overlap with an aberration).
Figure 2: Chromosome overviews are clearly displayed in CytoSure Interpret Software. Shown here is an overview of the distribution of probes on chromosome 2 in the CytoSure Medical Research Exome array and the currently available standard tracks. These fully customisable tracks simplify the interpretation of aberrations.
For more information on the CytoSure Medical Research Exome array, please contact us.
|CytoSure Medical Research Exome Array (1x1M)
||Microarray with one array of 1,000,000 spots; CytoSure Interpret Software
|Get a quote|
|CytoSure Custom Molecular Array
(1x1M, 2x400k, 4x180k or 8x60k)
|Microarray with one array of 1,000,000 spots; two arrays of 400,000 spots;
four arrays of 180,000 spots; or eight arrays of 60,000 spots; CytoSure Interpret Software
|700001||Get a quote|
|CytoSure Genomic DNA Labelling Kit||24 reactions: clean-up columns, dyes, nucleotide mix, random primers, enzyme, collection tubes||020022||Get a quote|
|CytoSure HT Genomic DNA Labelling Kit||96 reactions: 2 purification plates, nucleotide mix, random primers, enzyme, collection tubes||500040||Get a quote|
|CytoSure Sample Tracking Spike-ins A – H||Sample Tracking Probes sufficient for 12 reactions supplied in three aliquots||various||Get a quote|
CytoSure™ products are for research use only; not for use in diagnostic procedures.
Genomic analysis of rare disease
CNV plays an important role in rare disease. See how extensive CNV is across a range of rare diseases and how OGT can help you understand the complete mutation spectrum for each and every sample.
Integrated solutions for the genomic study of inherited disease
Our class-leading products are designed for the robust identification of the whole range of genomic variation, with an emphasis on custom solutions to target the regions important for your research.
OGT Product Catalogue
Including Cytocell FISH Probes for Cancer and Inherited Genetic Disease, CytoSure NGS and Array Products for Cytogenetics and Rare Disease, and SureSeq NGS Products for Haematology and Solid Tumour Cancers.
OGT USA Product Catalog 2017-2018
Evaluation of DNA labelling kits for enhanced microarray results
This application note provides a technical evaluation of CytoSure™ Genomic DNA Labelling Kits compared with another leading DNA labelling kit.
The impact of microarray probe design on detecting copy number variants at exon-resolution
Different factors need to be taken into account when designing microarrays to make sure that they offer robust performance across the targeted regions. Learn more about the process we undertake to make sure our arrays perform the best they possibly can.
The use of the InnoScan® 710 scanner and Mapix® software with CytoSure™ microarrays
This application note illustrates the use of the InnoScan 710 scanner and Mapix with a range of OGT CytoSure cytogenetic array formats.
Comprehensive genomic analysis — complementing sequencing with high-resolution CNV detection
This whitepaper discusses how researchers at Emory Genetics Laboratory (EGL) are complementing their sequencing results with accurate detection of copy number variants (CNVs) using CytoSure Molecular Arrays.
Evaluating and implementing CytoSure™ microarrays
In this white paper, Kath Smith, Consultant Clinical Scientist at Sheffield Children’s NHS Foundation Trust discusses her laboratory’s experience of transitioning to OGT CytoSure arrays.
Examining the medical exome
In this white paper, genetic scientists Dr Tracey Lewis and Dr Emily Farrow discuss how customisable, exon focused array designs complement next generation sequencing (NGS) for clinical genetic research.
Basics of array comparative genomic hybridisation (aCGH)
This poster illustrates the basics of how aCGH works and some of the applications in which it is used.
What’s wrong with my arrays?
Wet-lab processing is key to achieving the highest quality array data – find the solution to improve your data quality with our poster.